Literature DB >> 17294523

CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.

J H L Velthuis1, W M Mol, W Weimar, C C Baan.   

Abstract

CD4+ CD25bright+ FoxP3+ T cells are potent regulators of T-cell reactivity, but their possible involvement in donor-specific nonresponsiveness after clinical kidney transplantation remains to be elucidated. We assessed the proliferative donor-reactivity in 33 kidney allograft recipients who were maintained on a combination of proliferation inhibitors (mycophenolate mofetil (MMF) or Azathioprine (Aza)) and prednisone, long (> 5 years) after transplantation. Of the 33 patients, 8 still exhibited donor-reactivity, whereas 25 were classified as donor nonreactive patients. Within these 25 donor nonreactive patients, we assessed the involvement of CD4+ CD25bright+ regulatory T cells both by depleting them from the responder population as well as by reconstituting them to the CD25(-/dim) effector population. The absence of proliferation in these 25 patients, was abolished in 7 (28%) recipients upon depletion of the CD4+ CD25bright+ T cells. Reconstitution of these cells suppressed the donor-reactivity in a dose-dependent manner. Adding-back CD4+ CD25bright+ T cells inhibited the anti-third party response in all recipients, indicating that functional CD4+ CD25bright+ T cells circulate despite more then 5 years of immunosuppressive treatment. Altogether, we conclude that in long-term immunosuppressed kidney allograft patients functional regulatory CD4+ CD25bright+ T cells circulate but that these cells mediate donor non reactivity only in a subset of patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17294523     DOI: 10.1111/j.1600-6143.2006.01566.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  14 in total

1.  Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.

Authors:  Laure Vallotton; Karine Hadaya; Jean-Pierre Venetz; Leo H Buehler; Donatella Ciuffreda; Ghaleb Nseir; Laura Codarri; Jean Villard; Giuseppe Pantaleo; Manuel Pascual
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

2.  Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.

Authors:  Robert P Carroll; David San Segundo; Kevin Hollowood; Teresa Marafioti; Taane G Clark; Paul N Harden; Kathryn J Wood
Journal:  J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 10.121

Review 3.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

4.  Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.

Authors:  Z Wang; B-Y Shi; Y-Y Qian; M Cai; Q Wang
Journal:  Clin Exp Immunol       Date:  2009-01-07       Impact factor: 4.330

5.  Peripheral Treg count and it's determinants in unsensitized and sensitized chronic kidney disease patients.

Authors:  Cansu Topal; Sadi Köksoy; Gültekin Süleymanlar; Gülşen Yakuboğlu; F Fevzi Ersoy
Journal:  Int Urol Nephrol       Date:  2013-05-15       Impact factor: 2.370

6.  Flt3L combined with rapamycin promotes cardiac allograft tolerance by inducing regulatory dendritic cells and allograft autophagy in mice.

Authors:  Ali Xiong; Lihua Duan; Jie Chen; Zhigang Fan; Fang Zheng; Zheng Tan; Feili Gong; Min Fang
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

7.  On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation.

Authors:  Anja U Engela; Carla C Baan; Frank J M F Dor; Willem Weimar; Martin J Hoogduijn
Journal:  Front Immunol       Date:  2012-05-18       Impact factor: 7.561

8.  Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay.

Authors:  Ozlem Tapirdamaz; Shanta Mancham; Luc J W van der Laan; Geert Kazemier; Kris Thielemans; Herold J Metselaar; Jaap Kwekkeboom
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

9.  Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.

Authors:  Pervinder Sagoo; Giovanna Lombardi; Robert I Lechler
Journal:  Front Immunol       Date:  2012-07-13       Impact factor: 7.561

10.  Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.

Authors:  Ellen Kreijveld; Hans J P M Koenen; Bram van Cranenbroek; Esther van Rijssen; Irma Joosten; Luuk B Hilbrands
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.